Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy

Diabetes Research and Clinical Practice

Volumn 124, Issue , 2017, Pages 20-29

  Nakagami, Tomoko ^a   Takahashi, Kanako ^a,b   Suto, Chikako ^c,d   Oya, Junko ^a   Tanaka, Yuki ^a   Kurita, Moritoshi ^a   Isago, Chisato ^a   Hasegawa, Yukiko ^a   Ito, Arata ^a   Uchigata, Yasuko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Yoyogi Hospital   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d Saiseikai Kurihashi Hospital   (Japan)

Author keywords

Diabetes; Diagnostic criteria; Fasting plasma glucose; HbA1c; Incidence; Retinopathy

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EYE FUNDUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; ANALYSIS; BLOOD; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; REFERENCE VALUE; STANDARDS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES;

EID: 85008893190     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.12.013     Document Type: Article

References (30)

1. [1] McCance, D.R., Hanson, R.L., Charles, M.A., Jacobsson, L.T., Pettitt, D.J., Bennett, P.H., et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:6940 (1994), 1323–1328.
2. [2] Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:7 (1997), 1183–1197.
3. [3] Alberti, K.G., Zimmet, P.Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:7 (1998), 539–553.
4. [4] Engelgau, M.M., Thompson, T.J., Herman, W.H., Boyle, J.P., Aubert, R.E., Kenny, S.J., et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 20:5 (1997), 785–791.
5. [5] Colagiuri, S., Lee, C.M., Wong, T.Y., Balkau, B., Shaw, J.E., Borch-Johnsen, K., et al. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 34:1 (2011), 145–150.
6. [6] American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33:Suppl 1 (2010), S62–S69.
7. [7] World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation, < http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/>; 2011 [accessed 16.03.13].
8. [8] Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes MellitusSeino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 1:15 (2010), 212–228.
9. [9] Ito, C., Maeda, R., Ishida, S., Harada, H., Inoue, N., Sasaki, H., Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract 49:2–3 (2000), 181–186.
10. [10] Sabanayagam, C., Liew, G., Tai, E.S., Shankar, A., Lim, S.C., Subramaniam, T., et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?. Diabetologia 52:7 (2009), 1279–1289.
11. [11] Cheng, Y.J., Gregg, E.W., Geiss, L.S., Imperatore, G., Williams, D.E., Zhang, X., et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 32:11 (2009), 2027–2032.
12. [12] Xin, Z., Yuan, M.X., Li, H.X., Hua, L., Feng, J.P., Shi, J., et al. Evaluation for fasting and 2-hour glucose and Hb A1c for diagnosing diabetes based on prevalence of retinopathy in a chinese population. PLoS One, 7(7), 2012, e40610.
13. [13] Cho, N.A., Kim, T.H., Woo, S.J., Park, K.H., Lim, S., Cho, Y.M., et al. Optimal HbA1c cutoff for detecting diabetic retinopathy. Acta Diabetol 50:6 (2013), 837–842.
14. [14] Bower, J.K., Brancati, F.L., Selvin, E., No ethnic differences in the association of glycated hemoglobin with retinopathy: the national health and nutrition examination survey 2005–2008. Diabetes Care 36:3 (2013), 569–573.
15. [15] Mukai, N., Yasuda, M., Ninomiya, T., Hata, J., Hirakawa, Y., Ikeda, F., et al. Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study. Cardiovasc Diabetol, 13, 2014, 45.
16. [16] Sabanayagam, C., Khoo, E.Y., Lye, W.K., Ikram, M.K., Lamoureux, E.L., Cheng, C.Y., et al. Diagnosis of diabetes mellitus using HbA1c in Asians: relationship between HbA1c and retinopathy in a multiethnic Asian population. J Clin Endocrinol Metab 100:2 (2015), 689–696.
17. [17] Selvin, E., Ning, Y., Steffes, M.W., Bash, L.D., Klein, R., Wong, T.Y., et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 60:1 (2011), 298–305.
18. [18] Wong, T.Y., Liew, G., Tapp, R.J., Schmidt, M.I., Wang, J.J., Mitchell, P., et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 372:9614 (2008), 736–743.
19. [19] Tapp, R.J., Tikellis, G., Wong, T.Y., Harper, C.A., Zimmet, P.Z., Shaw, J.E., et al. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 31:7 (2008), 1349–1354.
20. [20] Wong, T.Y., Klein, R., Islam, F.M.A., Cotch, M.F., Couper, D.J., Klein, B.E.K., et al. Three-year incidence and cumulative prevalence of retinopathy: the atherosclerosis risk in communities study. Am J Ophthalmol 143:6 (2007), 970–976.
21. [21] van Leiden, H.A., Dekker, J.M., Moll, A.C., Nijpels, G., Heine, R.J., Bouter, L.M., et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121:2 (2003), 245–251.
22. [22] Cugati, S., Cikamatana, L., Wang, J.J., Kifley, A., Liew, G., Mitchell, P., Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study. Eye 20:11 (2006), 1239–1245.
23. [23] Massin, P., Lange, C., Tichet, J., Vol, S., Erginay, A., Cailleau, M., et al. Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol 129:2 (2011), 188–195.
24. [24] Wang, S., Xu, L., Jonas, J.B., Wang, Y.S., Wang, Y.X., You, Q.S., et al. Five-year incidence of retinal microvascular abnormalities and associations with arterial hypertension: the Beijing Eye Study 2001/2006. Ophthalmology 119:12 (2012), 2592–2599.
25. [25] Tsugawa, Y., Takahashi, O., Meigs, J.B., Davis, R.B., Imamura, F., Fukui, T., et al. New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy. Diabetes 61:12 (2012), 3280–3284.
26. [26] Xu, J., Xu, L., Wang, Y.X., You, Q.S., Jonas, J.B., Wei, W.B., Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011. PLoS One, 9(10), 2014, e111320.
27. [27] Fukuda, M., Classification and treatment of diabetic retinopathy. Diabetes Res Clin Pract 24:Suppl (1994), S171–S176.
28. [28] Bandello, F., Gass, J.D., Lattanzio, R., Brancato, R., Spontaneous regression of neovascularization at the disk and elsewhere in diabetic retinopathy. Am J Ophthalmol 122:4 (1996), 494–501.
29. [29] Alvarsson, M., Hilding, A., Ostenson, C.G., Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8–10-year follow-up. Diabet Med 26:4 (2009), 345–353.
30. [30] Hirano, T., Hemoglobinopathy in Japan: detection and analysis (Japanese). Rinsho Byori 47:3 (1999), 215–223.